Home-based Cognitive Bias Modification Training for Reducing Maladaptive Fear in Patients with Suspected Acute Coronary Syndrome: a Pilot Randomized Clinical Trial

Overview

Journal Pilot Feasibility Stud

Publisher Biomed Central

Date 2024 Jan 11

PMID 38212853

Authors

David Lopez-Veneros

Robin Cumella

Ian M Kronish

Amit Lazarov

Jeffrey L Birk

Affiliations

Soon will be listed here.

Abstract

Background: Patients evaluated in an emergency department for suspected acute coronary syndromes (ACS; e.g., myocardial infarction) often experience a lingering fear of recurrence, which may adversely affect their mental health and adherence to recommended health behaviors. Cognitive bias modification training (CBMT) is an acceptable, easy-to-use intervention that reduces fear of recurrence in cancer patients, and reduces fear and anxiety in other populations, providing an alternative to psychotherapy or counseling-based approaches. Feasibility testing is needed to assess whether a cardiac-related version of CBMT is acceptable to patients with elevated threat perceptions related to their suspected ACS.

Methods: We developed a tablet-based CBMT intervention tailored to reduce cardiac-related fear of recurrence. In this double-blinded feasibility trial, patients with elevated threat perceptions related to a recent suspected ACS were randomized either to a 4-week, 8-session, tablet-delivered intervention (CBMT) group or to a sham attention control group. Feasibility outcomes included the proportion of eligible patients who enrolled, drop-out rate, intervention compliance rate, acceptability/pleasantness and usability ratings, and task engagement (i.e., accuracy, response time).

Results: Of 49 eligible patients with suspected ACS and elevated threat perceptions recruited from NewYork-Presbyterian Hospital, over half (53.1%) enrolled after receiving a description of study procedures. Of the 26 randomized patients (mean age 59.15 years, 50% women), 2 patients (7.7%) dropped out. Additionally, 4 (15.4%) enrolled patients were not able to complete the tablet tasks, either due to difficulties with the technology or an inability to process the visually presented linguistic information at a sufficient speed. Still, among patients who returned the tablets (19 returned/20 received; 95%), most completed all assigned tablet tasks (intervention or control; 10/19; 52.6%), reporting that the tablets were easy to use and that the tasks were pleasant to complete.

Conclusion: Current findings suggest that cardiac-related CBMT is a promising and generally acceptable intervention for suspected ACS patients with cardiac-related threat perceptions which are akin to fear of recurrence. Nevertheless, challenges related to tablet usage indicate that the intervention user-experience should be further refined to optimize usability.

Trial Registration: Registered at ClinicalTrials.gov on 2/25/2019; NCT03853213. Registered with the Open Science Framework on 11/20/2017; https://osf.io/k7g8c/ .

References

White M, Edmondson D, Umland R, Sanchez G, Chang B . Patient perceptions of stress during evaluation for ACS in the ED. Am J Emerg Med. 2016; 35(2):351-352. PMC: 5728103. DOI: 10.1016/j.ajem.2016.10.053. View

Fodor L, Georgescu R, Cuijpers P, Szamoskozi S, David D, Furukawa T . Efficacy of cognitive bias modification interventions in anxiety and depressive disorders: a systematic review and network meta-analysis. Lancet Psychiatry. 2020; 7(6):506-514. DOI: 10.1016/S2215-0366(20)30130-9. View

Lee Y, Lai G, Lee D, Lai L, Chang Y . Promoting Physical and Psychological Rehabilitation Activities and Evaluating Potential Links Among Cancer-Related Fatigue, Fear of Recurrence, Quality of Life, and Physiological Indicators in Cancer Survivors. Integr Cancer Ther. 2018; 17(4):1183-1194. PMC: 6247550. DOI: 10.1177/1534735418805149. View

Vickberg S . The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003; 25(1):16-24. DOI: 10.1207/S15324796ABM2501_03. View

An J, Wang K, Jung Y, Cho S . Efficacy of Interpretation Bias Modification in Patients With Chronic Pain. J Pain. 2019; 21(5-6):648-662. DOI: 10.1016/j.jpain.2019.10.005. View

Dennis-Tiwary T, Denefrio S, Gelber S . Salutary effects of an attention bias modification mobile application on biobehavioral measures of stress and anxiety during pregnancy. Biol Psychol. 2017; 127:148-156. PMC: 5593765. DOI: 10.1016/j.biopsycho.2017.05.003. View

Ali Husain S, Edmondson D, Kautz M, Umland R, Kronish I . Posttraumatic stress disorder due to acute cardiac events and aversive cognitions towards cardiovascular medications. J Behav Med. 2017; 41(2):261-268. PMC: 5844812. DOI: 10.1007/s10865-017-9906-3. View

Hall D, Jimenez R, Perez G, Rabin J, Quain K, Yeh G . Fear of Cancer Recurrence: A Model Examination of Physical Symptoms, Emotional Distress, and Health Behavior Change. J Oncol Pract. 2019; 15(9):e787-e797. PMC: 6743221. DOI: 10.1200/JOP.18.00787. View

Sharpe L, Michalowski M, Richmond B, Menzies R, Shaw J . Fear of progression in chronic illnesses other than cancer: a systematic review and meta-analysis of a transdiagnostic construct. Health Psychol Rev. 2022; 17(2):301-320. DOI: 10.1080/17437199.2022.2039744. View

10.

Cristea I, Kok R, Cuijpers P . Efficacy of cognitive bias modification interventions in anxiety and depression: meta-analysis. Br J Psychiatry. 2015; 206(1):7-16. DOI: 10.1192/bjp.bp.114.146761. View

11.

Cornelius T, Agarwal S, Garcia O, Chaplin W, Edmondson D, Chang B . Development and Validation of a Measure to Assess Patients' Threat Perceptions in the Emergency Department. Acad Emerg Med. 2018; 25(10):1098-1106. PMC: 6185758. DOI: 10.1111/acem.13513. View

12.

Tayama J, Shimazu A, Ogawa S, Nakaya N . Effect of internet-based attention bias modification on the anxiety of Japanese workers: A randomized controlled trial. J Occup Health. 2021; 63(1):e12229. PMC: 8088281. DOI: 10.1002/1348-9585.12229. View

13.

Macdonald E, Koerner N, Antony M, Vickers K, Mastorakos T, Kuo J . Investigating the therapeutic potential of cognitive bias modification for high anxiety sensitivity. J Behav Ther Exp Psychiatry. 2019; 68:101521. DOI: 10.1016/j.jbtep.2019.101521. View

14.

Voils C, King H, Thorpe C, Blalock D, Kronish I, Reeve B . Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment. Dig Dis Sci. 2019; 64(10):2784-2797. DOI: 10.1007/s10620-019-05621-7. View

15.

Riddle M . News from the NIH: using an experimental medicine approach to facilitate translational research. Transl Behav Med. 2015; 5(4):486-8. PMC: 4656226. DOI: 10.1007/s13142-015-0333-0. View

16.

Guler E, Schmid J, Wiedemar L, Saner H, Schnyder U, von Kanel R . Clinical diagnosis of posttraumatic stress disorder after myocardial infarction. Clin Cardiol. 2009; 32(3):125-9. PMC: 6653086. DOI: 10.1002/clc.20384. View

17.

Booth M . Assessment of physical activity: an international perspective. Res Q Exerc Sport. 2015; 71 Suppl 2:114-20. DOI: 10.1080/02701367.2000.11082794. View

18.

Edmondson D, Kronish I, Shaffer J, Falzon L, Burg M . Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. Am Heart J. 2013; 166(5):806-14. PMC: 3815706. DOI: 10.1016/j.ahj.2013.07.031. View

19.

Meli L, Birk J, Edmondson D, Bonanno G . Trajectories of posttraumatic stress in patients with confirmed and rule-out acute coronary syndrome. Gen Hosp Psychiatry. 2019; 62:37-42. PMC: 9255559. DOI: 10.1016/j.genhosppsych.2019.11.006. View

20.

Lang F, Carstensen L . Time counts: future time perspective, goals, and social relationships. Psychol Aging. 2002; 17(1):125-139. DOI: 10.1037/0882-7974.17.1.125. View